BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 11818714)

  • 1. Prostate-specific antigen in hemodialysis patients and the influence of dialysis in its levels.
    Tzanakis I; Kazoulis S; Girousis N; Kagia S; Spandidakis V; Karefillakis N; Georgila M; Cristoulakis I; Hatzilias P; Kallivretakis N
    Nephron; 2002 Feb; 90(2):230-3. PubMed ID: 11818714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of chronic dialysis on serum PSA, free PSA, and free/total PSA ratio: is prostate cancer detection compromised in patients receiving long-term dialysis?
    Djavan B; Shariat S; Ghawidel K; Güven-Marberger K; Remzi M; Kovarik J; Hoerl WH; Marberger M
    Urology; 1999 Jun; 53(6):1169-74. PubMed ID: 10367847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of hemodialysis on serum complexed prostate-specific antigen levels.
    Tarhan F; Orçun A; Küçükercan I; Camursoy N; Kuyumcuoglu U
    Scand J Urol Nephrol; 2007; 41(5):382-6. PubMed ID: 17853041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percent-free prostate specific antigen is elevated in men on haemodialysis or peritoneal dialysis treatment.
    Bruun L; Björk T; Lilja H; Becker C; Gustafsson O; Christensson A
    Nephrol Dial Transplant; 2003 Mar; 18(3):598-603. PubMed ID: 12584285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percent free PSA as an additional measure in a prostate cancer screen.
    Miele ME
    Clin Lab Sci; 2001; 14(2):102-7. PubMed ID: 15625982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparisons of the various combinations of free, complexed, and total prostate-specific antigen for the detection of prostate cancer.
    Okegawa T; Noda H; Nutahara K; Higashihara E
    Eur Urol; 2000 Oct; 38(4):380-7. PubMed ID: 11025374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Significance and limitations of f/tPSA in differential diagnosis of prostate cancer with tPSA levels between 4 and 10 ng/ml].
    Chen ZD; Wei SM; Cai SL
    Zhonghua Wai Ke Za Zhi; 2004 May; 42(10):593-5. PubMed ID: 15265401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ratio of prostate-specific antigen (PSA) to prostate volume (PSA density) as a parameter to improve the detection of prostate carcinoma in PSA values in the range of < 4 ng/mL.
    Stephan C; Stroebel G; Heinau M; Lenz A; Roemer A; Lein M; Schnorr D; Loening SA; Jung K
    Cancer; 2005 Sep; 104(5):993-1003. PubMed ID: 16007682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the clinical validity of free prostate-specific antigen, alpha-1 antichymotrypsin-bound prostate-specific antigen and complexed prostate-specific antigen in prostate cancer diagnosis.
    Lein M; Jung K; Elgeti U; Petras T; Stephan C; Brux B; Sinha P; Winkelmann B; Schnorr D; Loening S
    Eur Urol; 2001 Jan; 39(1):57-64. PubMed ID: 11173940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic accuracy of percent free prostate-specific antigen in prostatic pathology and its usefulness in monitoring prostatic cancer patients.
    Minardi D; Galosi AB; Recchioni A; Giammarco L; Polito M; Muzzonigro G
    Urol Int; 2001; 67(4):272-82. PubMed ID: 11741128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of prostate specific antigen (PSA) and percentage free PSA in a contemporary screening cohort with no evidence of prostate cancer.
    Chun FK; Hutterer GC; Perrotte P; Gallina A; Valiquette L; Benard F; McCormack M; Briganti A; Ionescu C; Jeldres C; Guay JP; Saad F; Karakiewicz PI
    BJU Int; 2007 Jul; 100(1):37-41. PubMed ID: 17488305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of total prostate specific antigen and free to total prostate specific antigen ratio in the diagnosis of prostate cancer.
    Chakraborty L; Ahmed AN; Paul BK; Haque A; Ara A; Nabi S; Nessa M
    Mymensingh Med J; 2012 Jan; 21(1):98-102. PubMed ID: 22314462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aggressiveness of inflammation in histological prostatitis--correlation with total and free prostate specific antigen levels in men with biochemical criteria for prostate biopsy.
    Stimac G; Reljic A; Spajic B; Dimanovski J; Ruzic B; Ulamec M; Sonicki Z; Kraus O
    Scott Med J; 2009 Aug; 54(3):8-12. PubMed ID: 19725275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-specific reference ranges for prostate-specific antigen (PSA) in Jordanian patients.
    Battikhi MN
    Prostate Cancer Prostatic Dis; 2003; 6(3):256-60. PubMed ID: 12970732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ratio of alpha 1-antichymotrypsin--prostate specific antigen to total prostate specific antigen in prostate cancer diagnosis.
    Lein M; Jung K; Elgeti U; Brux B; Sinha P; Schnorr D; Loening SA
    Anticancer Res; 2000; 20(6D):4997-5001. PubMed ID: 11326657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic approach to prostate cancer using total prostate specific antigen-based parameters together.
    Serdar MA; Oguz O; Olgun A; Seçkin B; Ilgan S; Hasimi A; Salih M; Peker F; Kutluay T
    Ann Clin Lab Sci; 2002; 32(1):22-30. PubMed ID: 11848613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate specific-antigen distribution in asymptomatic Canadian men with no clinical evidence of prostate cancer.
    Chun FK; Perrotte P; Briganti A; Benayoun S; Lebeau T; Ramirez A; Lewinshtein DJ; Valiquette L; Guay JP; Karakiewicz PI
    BJU Int; 2006 Jul; 98(1):50-3. PubMed ID: 16831142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population-based analysis of normal Total PSA and percentage of free/Total PSA values: results from screening cohort.
    Capitanio U; Perrotte P; Zini L; Suardi N; Antebi E; Cloutier V; Jeldres C; Shariat SF; Duclos A; Arjane P; Saad F; Montorsi F; Karakiewicz PI
    Urology; 2009 Jun; 73(6):1323-7. PubMed ID: 19376563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accurate cut-off point for free to total prostate-specific antigen ratio used to improve differentiation of prostate cancer from benign prostate hyperplasia in Iranian population.
    Amirrasouli H; Kazerouni F; Sanadizade M; Sanadizade J; Kamalian N; Jalali M; Rahbar K; Karimi K
    Urol J; 2010 Jun; 7(2):99-104. PubMed ID: 20535696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate cancer screening with prostate-specific antigen in hemodialysis patients.
    Horinaga M; Kitamura K; Saito S; Ukimura O; Nakanoma T; Okihara K; Kitagawa M; Nakanishi H; Miki T
    Urol Int; 2007; 78(4):334-7. PubMed ID: 17495492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.